title: Effect of conjugated linoleic acid on body fat, tumor necrosis factor alpha and resistin secretion in spontaneously hypertensive rats.
abstract: Conjugated linoleic acid (CLA) is a naturally occurring group of dienoic derivaties of linoleic acid found mainly in beef and dairy products. CLA has been reported to reduce body fat, as well as to possess anticarcinogenic, antiatherogenic and procatabolic activities in animals. The objective of this study was to evaluate the effect of CLA supplementation to spontaneously hypertensive rats (SHR) on body fat, biochemical parameters of serum related tumor necrosis factor alpha (TNF-alpha) and resistin secretion. Thirty rats were divided in three groups, the first group of spontaneously hypertensive rats received a standard diet (V-SHR group, n=10), a second group of SHR was fed 1.5% of conjugated linoleic acid (CLA-SHR group, n=10) and the third was the control, non-hypertensive group (KW, n=10) also on a standard diet including 7.5% of sunflower oil during eight weeks. After CLA diet administration, spontaneously hypertensive rats showed a significant reduction in blood pressure, serum glucose, cholesterol and triacylglycerols, together with reduction of index of body fat, pericardic, abdominal and epididymal adipose tissue. These effects were accompanied by a decrease in the secretion of TNF-alpha and resistin.
authors.affiliation: UNIDA, Instituto Tecnológico de Veracruz M. A. de Quevedo 2779, Colonia Formando Hogar Veracruz, Veracruz, 91897 Mexico.
authors.forename: Guillermo
authors.initials: G
authors.lastname: Hernández-Díaz
authors.forename: Alfonso
authors.initials: A
authors.lastname: Alexander-Aguilera
authors.forename: Agustin
authors.initials: A
authors.lastname: Arzaba-Villalba
authors.forename: Ida
authors.initials: I
authors.lastname: Soto-Rodríguez
authors.forename: Hugo S
authors.initials: HS
authors.lastname: García
mesh_terms: D000273:Adipose Tissue / Q000187:drug effects*; D000818:Animals; D001786:Blood Glucose / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D019587:Dietary Supplements; D004195:Disease Models, Animal; D044243:Linoleic Acids, Conjugated / Q000627:therapeutic use*; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000188:drug therapy / Q000378:metabolism; D051381:Rats; D011918:Rats, Inbred SHR / Q000378:metabolism*; D052243:Resistin / Q000378:metabolism*; D014280:Triglycerides / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D001786:Blood Glucose; D044243:Linoleic Acids, Conjugated; D052243:Resistin; D014280:Triglycerides; D014409:Tumor Necrosis Factor-alpha; D002784:Cholesterol